PRKDC and neoplasm: The delivery of siRNA simultaneously targeting complementary pathways of the DNA damage repair process, ATM and DNApk-cs, resulted in greater radiosensitization than either siRNA alone, proving the ECO nanocarrier to be a versatile vehicle for blocking the many pathways associated with tumor survival.